Symbol
| DDB2
| contributors: mct - updated : 04-12-2018
|
HGNC name
| damage-specific DNA binding protein 2, 48kDa
|
HGNC id
| 2718
|
corresponding disease(s)
|
XPE
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
|  
|  
|
in xeroderma pigmentosum, type E | |
Susceptibility
|
to progressive supranuclear palsy (PSP) |
Variant & Polymorphism
SNP
| increasing the risk of progressive supranuclear palsy (PSP) |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | reproductive | prostate | |
may be a potential regimen for prostate cancer treatment, especially in androgen-refractory patients harboring high amount of AR who cannot be cured by androgen ablation |
| | | |
| DDB2–/– mice are susceptible to UV-induced skin carcinogenesis | |
mice genetically deficient in Ddb2 exhibited increased susceptibility to colon tumor development in a manner associated with higher abundance of the Wnt receptor-expressing cells and greater activation of the downstream Wnt pathway |